COVID-19 Impact on Lansoprazole Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Lansoprazole Industry
1.7 COVID-19 Impact: Lansoprazole Market Trends
2 Global Lansoprazole Quarterly Market Size Analysis
2.1 Lansoprazole Business Impact Assessment - COVID-19
2.1.1 Global Lansoprazole Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Lansoprazole Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Lansoprazole Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Lansoprazole Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Lansoprazole Factory Price by Manufacturers
3.3 Location of Key Manufacturers Lansoprazole Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Lansoprazole Market
3.5 Key Manufacturers Lansoprazole Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Lansoprazole Segments, By Type
4.1 Introduction
1.4.1 Capsules
1.4.2 OD Tablet
1.4.3 Injection
4.2 By Type, Global Lansoprazole Market Size, 2019-2021
4.2.1 By Type, Global Lansoprazole Market Size by Type, 2020-2021
4.2.2 By Type, Global Lansoprazole Price, 2020-2021
5 Impact of Covid-19 on Lansoprazole Segments, By Application
5.1 Overview
5.5.1 Male
5.5.2 Female
5.2 By Application, Global Lansoprazole Market Size, 2019-2021
5.2.1 By Application, Global Lansoprazole Market Size by Application, 2019-2021
5.2.2 By Application, Global Lansoprazole Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Takeda Pharmaceutical
7.1.1 Takeda Pharmaceutical Business Overview
7.1.2 Takeda Pharmaceutical Lansoprazole Quarterly Production and Revenue, 2020
7.1.3 Takeda Pharmaceutical Lansoprazole Product Introduction
7.1.4 Takeda Pharmaceutical Response to COVID-19 and Related Developments
7.2 Teva Pharms
7.2.1 Teva Pharms Business Overview
7.2.2 Teva Pharms Lansoprazole Quarterly Production and Revenue, 2020
7.2.3 Teva Pharms Lansoprazole Product Introduction
7.2.4 Teva Pharms Response to COVID-19 and Related Developments
7.3 Sandoz
7.3.1 Sandoz Business Overview
7.3.2 Sandoz Lansoprazole Quarterly Production and Revenue, 2020
7.3.3 Sandoz Lansoprazole Product Introduction
7.3.4 Sandoz Response to COVID-19 and Related Developments
7.4 GSK
7.4.1 GSK Business Overview
7.4.2 GSK Lansoprazole Quarterly Production and Revenue, 2020
7.4.3 GSK Lansoprazole Product Introduction
7.4.4 GSK Response to COVID-19 and Related Developments
7.5 Dr. Reddy's
7.5.1 Dr. Reddy's Business Overview
7.5.2 Dr. Reddy's Lansoprazole Quarterly Production and Revenue, 2020
7.5.3 Dr. Reddy's Lansoprazole Product Introduction
7.5.4 Dr. Reddy's Response to COVID-19 and Related Developments
7.6 Pfizer
7.6.1 Pfizer Business Overview
7.6.2 Pfizer Lansoprazole Quarterly Production and Revenue, 2020
7.6.3 Pfizer Lansoprazole Product Introduction
7.6.4 Pfizer Response to COVID-19 and Related Developments
7.7 Taj Pharma
7.7.1 Taj Pharma Business Overview
7.7.2 Taj Pharma Lansoprazole Quarterly Production and Revenue, 2020
7.7.3 Taj Pharma Lansoprazole Product Introduction
7.7.4 Taj Pharma Response to COVID-19 and Related Developments
7.8 Mylan
7.8.1 Mylan Business Overview
7.8.2 Mylan Lansoprazole Quarterly Production and Revenue, 2020
7.8.3 Mylan Lansoprazole Product Introduction
7.8.4 Mylan Response to COVID-19 and Related Developments
7.9 Cisen Pharmaceutical
7.9.1 Cisen Pharmaceutical Business Overview
7.9.2 Cisen Pharmaceutical Lansoprazole Quarterly Production and Revenue, 2020
7.9.3 Cisen Pharmaceutical Lansoprazole Product Introduction
7.9.4 Cisen Pharmaceutical Response to COVID-19 and Related Developments
7.10 Lepu Pharmaceuticals
7.10.1 Lepu Pharmaceuticals Business Overview
7.10.2 Lepu Pharmaceuticals Lansoprazole Quarterly Production and Revenue, 2020
7.10.3 Lepu Pharmaceuticals Lansoprazole Product Introduction
7.10.4 Lepu Pharmaceuticals Response to COVID-19 and Related Developments
7.11 Nang Kuang Pharmaceutical
7.11.1 Nang Kuang Pharmaceutical Business Overview
7.11.2 Nang Kuang Pharmaceutical Lansoprazole Quarterly Production and Revenue, 2020
7.11.3 Nang Kuang Pharmaceutical Lansoprazole Product Introduction
7.11.4 Nang Kuang Pharmaceutical Response to COVID-19 and Related Developments
7.12 Luoxin Biotechnology
7.12.1 Luoxin Biotechnology Business Overview
7.12.2 Luoxin Biotechnology Lansoprazole Quarterly Production and Revenue, 2020
7.12.3 Luoxin Biotechnology Lansoprazole Product Introduction
7.12.4 Luoxin Biotechnology Response to COVID-19 and Related Developments
7.13 Beijing Honglin Pharma.
7.13.1 Beijing Honglin Pharma. Business Overview
7.13.2 Beijing Honglin Pharma. Lansoprazole Quarterly Production and Revenue, 2020
7.13.3 Beijing Honglin Pharma. Lansoprazole Product Introduction
7.13.4 Beijing Honglin Pharma. Response to COVID-19 and Related Developments
7.14 Suzhou YUSHI Pharmaceutical Co.
7.14.1 Suzhou YUSHI Pharmaceutical Co. Business Overview
7.14.2 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Quarterly Production and Revenue, 2020
7.14.3 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Introduction
7.14.4 Suzhou YUSHI Pharmaceutical Co. Response to COVID-19 and Related Developments
7.15 Changzhou Siyao Pharmaceuticals
7.15.1 Changzhou Siyao Pharmaceuticals Business Overview
7.15.2 Changzhou Siyao Pharmaceuticals Lansoprazole Quarterly Production and Revenue, 2020
7.15.3 Changzhou Siyao Pharmaceuticals Lansoprazole Product Introduction
7.15.4 Changzhou Siyao Pharmaceuticals Response to COVID-19 and Related Developments
7.16 Youcare Pharmaceutical Group
7.16.1 Youcare Pharmaceutical Group Business Overview
7.16.2 Youcare Pharmaceutical Group Lansoprazole Quarterly Production and Revenue, 2020
7.16.3 Youcare Pharmaceutical Group Lansoprazole Product Introduction
7.16.4 Youcare Pharmaceutical Group Response to COVID-19 and Related Developments
7.17 HOPE PHARMA
7.17.1 HOPE PHARMA Business Overview
7.17.2 HOPE PHARMA Lansoprazole Quarterly Production and Revenue, 2020
7.17.3 HOPE PHARMA Lansoprazole Product Introduction
7.17.4 HOPE PHARMA Response to COVID-19 and Related Developments
7.18 Sun Pharmaceutical Industries
7.18.1 Sun Pharmaceutical Industries Business Overview
7.18.2 Sun Pharmaceutical Industries Lansoprazole Quarterly Production and Revenue, 2020
7.18.3 Sun Pharmaceutical Industries Lansoprazole Product Introduction
7.18.4 Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
7.19 Krka
7.19.1 Krka Business Overview
7.19.2 Krka Lansoprazole Quarterly Production and Revenue, 2020
7.19.3 Krka Lansoprazole Product Introduction
7.19.4 Krka Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Lansoprazole Supply Chain Analysis
8.1.1 Lansoprazole Supply Chain Analysis
8.1.2 Covid-19 Impact on Lansoprazole Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Lansoprazole Distribution Channels
8.2.2 Covid-19 Impact on Lansoprazole Distribution Channels
8.2.3 Lansoprazole Distributors
8.3 Lansoprazole Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Lansoprazole Assessment
Table 9. COVID-19 Impact: Lansoprazole Market Trends
Table 10. COVID-19 Impact Global Lansoprazole Market Size
Table 11. Global Lansoprazole Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Lansoprazole Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Lansoprazole Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Lansoprazole Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Lansoprazole Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Lansoprazole Market Growth Drivers
Table 17. Global Lansoprazole Market Restraints
Table 18. Global Lansoprazole Market Opportunities
Table 19. Global Lansoprazole Market Challenges
Table 20. Key Manufacturers Lansoprazole Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Lansoprazole Market Size, 2019 (K Units) & (US$ Million)
Table 22. Lansoprazole Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Lansoprazole Manufacturing Plants
Table 24. Key Manufacturers Lansoprazole Market Served
Table 25. Date of Key Manufacturers Enter into Lansoprazole Market
Table 26. Key Manufacturers Lansoprazole Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Lansoprazole Market Size by Type, 2020, (US$ Million)
Table 29. Global Lansoprazole Market Size by Type, 2020 (K Units)
Table 30. Global Lansoprazole Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Lansoprazole Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Lansoprazole Market Size by Application, 2020-2021 (K Units)
Table 33. Global Lansoprazole Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Lansoprazole Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Lansoprazole Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Lansoprazole Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Lansoprazole Market Size, 2019-2021 (K Units)
Table 38. US Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Lansoprazole Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Lansoprazole Market Size, 2019-2021 (K Units)
Table 43. Germany Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Lansoprazole Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Lansoprazole Market Size, 2019-2021 (K Units)
Table 50. China Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Lansoprazole Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Takeda Pharmaceutical Business Overview
Table 58. Takeda Pharmaceutical Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Takeda Pharmaceutical Lansoprazole Product
Table 60. Takeda Pharmaceutical Response to COVID-19 and Related Developments
Table 61. Teva Pharms Business Overview
Table 62. Teva Pharms Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Teva Pharms Lansoprazole Product
Table 64. Teva Pharms Response to COVID-19 and Related Developments
Table 65. Sandoz Business Overview
Table 66. Sandoz Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Sandoz Lansoprazole Product
Table 68. Sandoz Response to COVID-19 and Related Developments
Table 69. GSK Business Overview
Table 70. GSK Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. GSK Lansoprazole Product
Table 72. GSK Response to COVID-19 and Related Developments
Table 73. Dr. Reddy's Business Overview
Table 74. Dr. Reddy's Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Dr. Reddy's Lansoprazole Product
Table 76. Dr. Reddy's Response to COVID-19 and Related Developments
Table 77. Pfizer Business Overview
Table 78. Pfizer Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Pfizer Lansoprazole Product
Table 80. Pfizer Response to COVID-19 and Related Developments
Table 81. Taj Pharma Business Overview
Table 82. Taj Pharma Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Taj Pharma Lansoprazole Product
Table 84. Taj Pharma Response to COVID-19 and Related Developments
Table 85. Mylan Business Overview
Table 86. Mylan Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Mylan Lansoprazole Product
Table 88. Mylan Response to COVID-19 and Related Developments
Table 89. Cisen Pharmaceutical Business Overview
Table 90. Cisen Pharmaceutical Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Cisen Pharmaceutical Lansoprazole Product
Table 92. Cisen Pharmaceutical Response to COVID-19 and Related Developments
Table 93. Lepu Pharmaceuticals Business Overview
Table 94. Lepu Pharmaceuticals Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Lepu Pharmaceuticals Lansoprazole Product
Table 96. Lepu Pharmaceuticals Response to COVID-19 and Related Developments
Table 97. Nang Kuang Pharmaceutical Business Overview
Table 98. Nang Kuang Pharmaceutical Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Nang Kuang Pharmaceutical Lansoprazole Product
Table 100. Nang Kuang Pharmaceutical Response to COVID-19 and Related Developments
Table 101. Luoxin Biotechnology Business Overview
Table 102. Luoxin Biotechnology Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Luoxin Biotechnology Lansoprazole Product
Table 104. Luoxin Biotechnology Response to COVID-19 and Related Developments
Table 105. Beijing Honglin Pharma. Business Overview
Table 106. Beijing Honglin Pharma. Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Beijing Honglin Pharma. Lansoprazole Product
Table 108. Beijing Honglin Pharma. Response to COVID-19 and Related Developments
Table 109. Suzhou YUSHI Pharmaceutical Co. Business Overview
Table 110. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product
Table 112. Suzhou YUSHI Pharmaceutical Co. Response to COVID-19 and Related Developments
Table 113. Changzhou Siyao Pharmaceuticals Business Overview
Table 114. Changzhou Siyao Pharmaceuticals Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Changzhou Siyao Pharmaceuticals Lansoprazole Product
Table 116. Changzhou Siyao Pharmaceuticals Response to COVID-19 and Related Developments
Table 117. Youcare Pharmaceutical Group Business Overview
Table 118. Youcare Pharmaceutical Group Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Youcare Pharmaceutical Group Lansoprazole Product
Table 120. Youcare Pharmaceutical Group Response to COVID-19 and Related Developments
Table 121. HOPE PHARMA Business Overview
Table 122. HOPE PHARMA Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. HOPE PHARMA Lansoprazole Product
Table 124. HOPE PHARMA Response to COVID-19 and Related Developments
Table 125. Sun Pharmaceutical Industries Business Overview
Table 126. Sun Pharmaceutical Industries Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Sun Pharmaceutical Industries Lansoprazole Product
Table 128. Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
Table 129. Krka Business Overview
Table 130. Krka Lansoprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Krka Lansoprazole Product
Table 132. Krka Response to COVID-19 and Related Developments
Table 133. Lansoprazole Distributors List
Table 134. Lansoprazole Customers List
Table 135. Covid-19 Impact on Lansoprazole Customers
List of FiguresFigure 1. Lansoprazole Product Picture
Figure 2. Lansoprazole Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Lansoprazole Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Lansoprazole Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Lansoprazole Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Lansoprazole Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Lansoprazole Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Lansoprazole Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Lansoprazole Market Size Market Share, 2019-2021